Omicron continues to appear milder than earlier coronavirus variants, scientists and doctors said,, but its heightened transmissibility has resulted in large numbers of hospitalizations
A record number of Covid-19 cases driven by the Omicron variant is putting hospitals under increasing pressure in parts of the U.S. and Europe.
Omicron continues to appear milder than earlier coronavirus variants, scientists and doctors said, particularly in people who have been vaccinated or have suffered a previous infection. But its heightened transmissibility has pushed Covid-19 infections to unprecedented levels, resulting in large numbers of hospitalizations.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
U.S. Covid-19 Cases Set to Triple Pre-Omicron RecordThe seven-day average of newly reported Covid-19 infections in the U.S. is on track to triple the pre-Omicron record set a year ago, when America saw a quarter million daily cases.
Lire la suite »
U.S. breaks COVID-19 hospitalization record at over 132,000 as Omicron surgesCOVID-19 hospitalizations in the United States reached a record high on Monday, according to a Reuters tally, as a surge in infections caused by the highly contagious Omicron variant strains health systems in several states.
Lire la suite »
Too soon to treat COVID-19 like flu as Omicron spreads - WHOThe Omicron variant of COVID-19 is on track to infect more than half of Europeans, but it should not yet be seen as a flu-like endemic illness, the World Health Organization (WHO) said on Tuesday.
Lire la suite »
Covid-19 testing in the time of omicron: Everything you need to knowIf your omicron symptoms get better are you still infectious? Are lateral flow tests good at detecting omicron? Why have some countries changed their testing and isolation guidelines? Everything you need to know about testing in the omicron wave
Lire la suite »
Avacta pauses sales of COVID-19 antigen test to boost Omicron sensitivityBritish biotech firm Avacta Group said on Monday it was halting sales of its COVID-19 antigen lateral flow test, AffiDX, to replace antibodies in the device and boost its ability to detect the Omicron coronavirus variant at lower viral loads.
Lire la suite »
Avacta pauses sales of COVID-19 antigen test to improve Omicron sensitivityBritain's Avacta Group is halting sales of its COVID-19 rapid antigen lateral flow test to replace antibodies in the device and boost its ability to detect the Omicron variant, the biotech firm said on Monday, sending its shares plunging nearly 27%.
Lire la suite »